Kolexia
Chamouard-Cogoluenhes Valerie
Pharmacien
Hôpital Louis Pradel
Bron, France
110 Activités
45 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Maladies de von Willebrand Urgences Maladies rares Déficit en alpha-1-antitrypsine Hémophilie B Déficits en facteurs de la coagulation Angioedème

Industries

LFB
16 collaboration(s)
Dernière en 2023
Roche
8 collaboration(s)
Dernière en 2023
Sobi
7 collaboration(s)
Dernière en 2023
Pfizer
6 collaboration(s)
Dernière en 2023

Dernières activités

Comparison of one-stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII-Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single-centre, real-world experience of surgery.
Haemophilia : the official journal of the World Federation of Hemophilia   27 décembre 2023
A single-centre experience of 29 total ankle replacement in haemophiliac patients: Therapeutic management, factor consumption and cost.
Haemophilia : the official journal of the World Federation of Hemophilia   11 décembre 2023
Perspectives and perception of haemophilia gene therapy by French patients.
Haemophilia : the official journal of the World Federation of Hemophilia   06 décembre 2023
Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey.
Haemophilia : the official journal of the World Federation of Hemophilia   17 septembre 2023
Hémophilie
HAS Publications   20 juin 2023
Atteinte pulmonaire associée à un déficit en alpha1-antitrypsine
HAS Publications   23 mars 2023
IVIg therapy in the management of BK virus infections in pediatric kidney transplant patients.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie   10 mars 2023
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model.
JMIR research protocols   08 mars 2023
PASODOBLEDEMI2: Evaluation of the Evolution of the Patient Care Pathway in the Context of the Implementation of the DOuBLE EMIcizumab Dispensing Circuit in France
Essai Clinique (Hospices Civils de Lyon)   02 mars 2023
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders.
European journal of haematology   20 février 2023